Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and Sclerosis, Systemic

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LeRoy, EC; Ludwicka, A; McDonald, JK; Ohba, T; Silver, RM; Strange, C1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Sclerosis, Systemic

ArticleYear
Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.
    American journal of respiratory cell and molecular biology, 1994, Volume: 10, Issue:4

    Topics: Adult; Amino Acid Chloromethyl Ketones; Antibodies; Antithrombins; Becaplermin; Bronchoalveolar Lavage Fluid; Cell Division; Cell Line; DNA; Fibroblasts; Humans; Lung; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Receptors, Platelet-Derived Growth Factor; Recombinant Proteins; RNA; Scleroderma, Systemic; Thrombin; Up-Regulation

1994